Structure and ligand based design for identification of highly potent molecules against 5-LOX

被引:0
|
作者
Kaur, Rajbir [1 ]
Rani, Sudesh [1 ]
Singh, Palwinder [1 ]
机构
[1] Guru Nanak Dev Univ, UGC Sponsored Ctr Adv Studies, Dept Chem, Amritsar 143005, India
关键词
Inflammation; 5-Lipoxygenase; Structure and ligand-based design; Inhibitors; 5-LIPOXYGENASE; CANCER; LEUKOTRIENES; BIOCHEMISTRY; INHIBITORS; ROLES; ACID;
D O I
10.1016/j.bmcl.2023.129448
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report here small molecules consisting of dichlorophenyl substituted oxindole that is further tagged with pyrrole/indole moieties. These molecules were designed on the basis of the analysis of binding mode of 5-LOX with arachidonic acid and zileuton. The molecules traverse the active site pocket of the enzyme that otherwise hosts AA and zileuton. Moreover, with a provision of derivatization at pyrrole/indole-N, the physico-chemical properties of the molecules can be adjusted. Appreciable 5-LOX inhibitory activities of the compounds in submicromolar range were observed and their aqueous solubility, binding with human serum albumin and stability in blood plasma and liver microsomes were checked. The Michaelis-Menten constants obtained during the binding of the compounds with 5-LOX indicated competitive binding of the compounds with the enzyme. Overall, the combination of molecular modelling and experimental studies identified promising molecules against inflammatory diseases.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Structure and Ligand Based Drug Design Strategies in the Development of Novel 5-LOX Inhibitors
    Aparoy, Polamarasetty
    Reddy, Kakularam Kumar
    Reddanna, Pallu
    [J]. CURRENT MEDICINAL CHEMISTRY, 2012, 19 (22) : 3763 - 3778
  • [2] Identification of Therapeutically Active Molecules against Anthrax through Structure and Ligand based Drug Design
    Nandi, Sisir
    Saxena, Mridula
    Saxena, Anil Kumar
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (27) : 2294 - 2312
  • [3] Design of Dual COX-2 and 5-LOX Inhibitors with Iron-Chelating Properties Using Structure-Based and Ligand-Based Methods
    Boskovic, Jelena
    Ruzic, Dusan
    Cudina, Olivera
    Nikolic, Katarina
    Dobricic, Vladimir
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (04) : 279 - 292
  • [4] Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening
    Cerchia, Carmen
    Kuefner, Laura
    Werz, Oliver
    Lavecchia, Antonio
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 263
  • [5] Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders
    Razavi, Seyed Mehrad
    Khayatan, Danial
    Arab, Zahra Najafi
    Momtaz, Saeideh
    Zare, Kimia
    Jafari, Razieh Mohammad
    Dehpour, Ahmad Reza
    Abdolghaffari, Amir Hossein
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2021, 157
  • [6] Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors
    Reddy, Nimmanapalli P.
    Aparoy, Polamarasetty
    Reddy, T. Chandra Mohan
    Achari, Chandrani
    Sridhar, P. Ramu
    Reddanna, Pallu
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (16) : 5807 - 5815
  • [7] Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies
    Subramani, Muthuraman
    Sinha, Shweta
    Vasavi, C. S.
    Waidha, Kamran Manzoor
    Basu, Biswarup
    Munussami, Punnagai
    Balamurali, M. M.
    Doble, Mukesh
    Rajendran, Saravana Kumar
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (04) : 604 - 619
  • [8] Lead modification: Amino acid appended indoles as highly effective 5-LOX inhibitors
    Prasher, Parteek
    Pooja
    Singh, Palwinder
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (05) : 1642 - 1648
  • [9] 2-Amino-4-aryl thiazole: a promising scaffold identified as a potent 5-LOX inhibitor
    Sinha, Shweta
    Sravanthi, T. V.
    Yuvaraj, S.
    Manju, S. L.
    Doble, Mukesh
    [J]. RSC ADVANCES, 2016, 6 (23): : 19271 - 19279
  • [10] Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation
    Neukirch, Konstantin
    Alsabil, Khaled
    Dinh, Chau-Phi
    Bilancia, Rossella
    Raasch, Martin
    Ville, Alexia
    Cerqua, Ida
    Viault, Guillaume
    Breard, Dimitri
    Pace, Simona
    Temml, Veronika
    Brunner, Elena
    Jordan, Paul M.
    Marques, Marta C.
    Loeser, Konstantin
    Gollowitzer, Andre
    Permann, Stephan
    Gerstmeier, Jana
    Lorkowski, Stefan
    Stuppner, Hermann
    Garscha, Ulrike
    Rodrigues, Tiago
    Bernardes, Goncalo J. L.
    Schuster, Daniela
    Seraphin, Denis
    Richomme, Pascal
    Rossi, Antonietta
    Mosig, Alexander S.
    Roviezzo, Fiorentina
    Werz, Oliver
    Helesbeux, Jean-Jacques
    Koeberle, Andreas
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) : 11496 - 11526